Prolonging organ allograft survival: Potential role of nitric oxide scavengers

BioDrugs

Volumn 16, Issue 1, 2002, Pages 37-45

  Pieper, Galen M ^a   Khanna, Ashwani K ^a   Roza, Allan M ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMD 6221; AMINOGUANIDINE; COBALT COMPLEX; CYCLOSPORIN; CYTOKINE; DITHIOCARBAMIC ACID DERIVATIVE; GAMMA INTERFERON; HEAT SHOCK PROTEIN 72; HEMOGLOBIN; IMMUNOSUPPRESSIVE AGENT; METAL COMPLEX; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; N6 (1 IMINOETHYL)LYSINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; NOX 100; NOX 700; RUTHENIUM DERIVATIVE; SCAVENGER; UNCLASSIFIED DRUG;

ACUTE DISEASE; ANIMAL CELL; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; CHRONIC DISEASE; CONTROLLED STUDY; DRUG POTENTIATION; ELECTRON SPIN RESONANCE; GENE DELETION; GENE EXPRESSION; GENETIC TRANSCRIPTION; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KNOCKOUT MOUSE; LUNG TRANSPLANTATION; MIXED LYMPHOCYTE CULTURE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RAT; REVIEW; SPLEEN CELL;

EID: 0036229347     PISSN: 11738804     EISSN: None     Source Type: Journal    
DOI: 10.2165/00063030-200216010-00004     Document Type: Review

References (73)

1. Sequential cellular and molecular kinetics in acutely rejecting renal allografts in rats
2. Urinary nitrate excretion is a noninvasive indicator of acute cardiac allograft rejection and nitric oxide production in the rat
3. Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase
4. Increased serum nitrate concentration in cardiac transplant patients
5. Nitric oxide generation. A predictive parameter of acute allograft rejection
6. Reduction of myocardial nitrosyl complex formation by a nitric oxide scavenger prolongs cardiac allograft survival
7. Induction of myocardial nitric oxide synthase by cardiac allograft rejection
8. Effects of immunosuppressive therapy on expression of inducible nitric oxide synthase (iNOS) during cardiac allograft rejection
9. Cellular localization and effect of nitric oxide synthase in a rat model of orthotopic liver transplantation
10. Peroxynitrite formation during rat hepatic allograft rejection
11. Alterations in mRNA for inducible and endothelial nitric oxide synthase and plasma nitric oxide with rejection and/or infection of allotransplanted lung
12. Nitric oxide production and nitric oxide synthase expression in acute human renal allograft rejection
13. Detection of nitric oxide by electron paramagnetic resonance spectroscopy during rejection and graft-versus-host disease after small-bowel transplantation in the rat
14. Corticosteroids inhibit expression of inducible nitric oxide synthase during acute cardiac allograft rejection
15. Inhibition of inducible nitric oxide synthase attenuates established acute cardiac allograft rejection
16. Role of nitric oxide and superoxide in acute cardiac allograft rejection in rats
17. Acute cardiac allograft rejection in nitric oxide synthase-2-/-and nitric oxide synthase-2+/+ mice. Effects of cellular chimeras on myocardial inflammation and cardiomyocyte damage and apoptosis
18. Apoptosis and increased expression of inducible nitric oxide synthase in human allograft rejection
19. Differential localization of allograft nitric oxide synthesis: Comparison of liver and heart transplantation in the rat model
20. Relative importance of cytotoxic T lymphocytes and nitric-oxide dependent cytotoxicity in contractile dysfunction of rejecting murine cardiac allografts
21. Selective inhibition of nitric oxide production during cardiac allograft rejection causes a small increase in graft survival
22. Nω-monomethyl-L-arginine inhibits nitric oxide production in murine cardiac allografts but does not affect graft rejection
23. Nitric oxide synthase inhibition is associated with decreased survival of cardiac allografts in the rat
24. Nitric oxide: An endogenous modulator of leukocyte adhesion
25. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium
26. Nitric oxide synthase induction and chronic cardiac allograft rejection
27. Improvement of rejection-induced diastolic abnormalities in rat cardiac allografts with inducible nitric oxide synthase inhibition
28. Electron spin resonance analysis of heme-nitrosyl and reduced iron-sulfur centred complexes in allogeneic, heterotopic cardiac transplants: Effects of treatment with pyrrolidine dithiocarbamate
29. Inducible nitric oxide-mediated myocardial apoptosis contributes to graft failure during acute cardiac allograft rejection in mice
30. Inhibition of inducible nitric oxide synthase ameliorates rat lung allograft rejection
31. Inhibition of inducible nitric oxide synthase improves graft function and reduces tubulointerstitial injury in renal allograft rejection
32. NOS2 mediates opposing effects in models of acute and chronic cardiac rejection
33. Attenuated acute cardiac rejection in NOS2 -/-recipients correlates with reduced apoptosis
34. Inducible nitric oxide synthase promotes cytokine expression in cardiac allografts but is not required for efficient rejection
35. Exacerbated transplant arteriosclerosis in inducible nitric oxide-deficient mice
36. Mice lacking inducible nitric oxide synthase develop spontaneous hypercholesterolaemia and aortic atheromas
37. Spin trapping of nitric oxide produced in vivo in septic-shock mice
38. NOX, a novel nitric oxide scavenger, reduces bacterial translocation in rats after endotoxin challenge
39. A novel nitric oxide scavenger decreases liver injury and improves survival after hemorrhagic shock
40. Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates
41. Gamma interferon induced nitric oxide production reduces Chlamydia trachomatis infectivity in McCoy cells
42. Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase
43. Current aspects in pharmacology of modified hemoglobins
44. Pyridoxalated hemoglobin polyoxyethylene: A nitric oxide scavenger with antioxidant activity for the treatment of nitric oxide-induced shock
45. Spectroscopic studies of nitric oxide (NO) interactions with cobalamins: Reaction of NO with superoxocobalamin (III) likely accounts for cobalamin reversal of the biological effects of NO
46. Nitrogen monoxide-related disease and nitrogen monoxide scavengers as potential drugs
47. Superoxide-dependent and -independent mechanisms of iron mobilization from ferritin by xanthine oxidase. Implications for oxygen-free radical-induced tissue destruction during ischaemia and inflammation
48. Iron mobilization from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes. Possible mechanism in inflammation diseases
49. Nitric oxide mediates iron release from ferritin
50. Effects of nitric oxide scavenging and inhibition of NF-κB activity on cardiac allograft survival
51. NOX100, a nitric oxide scavenger, enhances cardiac allograft survival and promotes long-term graft acceptance
52. Effects of antioxidant therapy on alloimmune activation and NF-κB-dependent inflammatory cytokine gene expression
53. A ruthenium (III) polyaminocarboxylate complex, a novel nitric oxide scavenger, enhances graft survival and decreases nitrosylated heme protein in models of acute and delayed cardiac transplant rejection
54. Skin allograft rejection in mice lacking inducible nitric oxide synthase
55. Attenuation of renal ischemia-reperfusion injury in inducible nitric oxide synthase knockout mice
56. Inducible nitric oxide synthase knockout mouse macrophages disclose prooxidant effect on interferon-γ on low-density lipoprotein oxidation
57. Endothelial nitric oxide synthase protects aortic allografts from the development of transplant arteriosclerosis
58. Distribution and function of recombinant endothelial nitric oxide synthase in transplanted hearts
59. Permeability of nitric oxide through lipid bilayer membranes
60. Accelerated reaction of nitric oxide with O2 within the hydrophobic interior of biological membranes
61. Cellular antioxidant and pro-oxidant action of nitric oxide
62. Spin trapping for nitric oxide produced in LPS-treated mouse using various new dithiocarbamate iron complexes having substituted proline and serine moiety
63. Role of nitric oxide in cardiac transplant rejection: Documentation by EPR spectroscopy and other techniques
64. Complexes of Fe2+ with diethyldithiocarbamate or N-methyl-D-glucamine dithiocarbamate as traps of nitric oxide in animal tissues: Comparative investigations
65. Nitric oxide-forming reactions of the water-soluble nitric oxide spin-trapping agent, MGD
66. Antioxidant capacity of mononitrosyl-iron-dithiocarbamate complexes: Implications for NO trapping
67. In vivo electron paramagnetic resonance imaging of NO-bound iron complex in a rat head
68. The physiological activity and in vivo distribution of dinitrosyl dithiolato iron complex
69. In vivo EPR detection and imaging of endogenous nitric oxide in lipopolysaccharide-treated mice
70. Electron paramagnetic resonance imaging of the rat heart
71. Detection of nitrosyl-iron complexes by proton-electron-double-resonance imaging
72. In vivo imaging of spin-trapped nitric oxide in rats with septic shock: MRI spin trapping
73. Development of separable electron spin resonance-computed tomography imaging for multiple radical species: An application to OH and NO